Allogeneic Stem Cell Transplantation for AML Patients with RUNX1 Mutation in First Complete Remission: A Study on Behalf of the ALWP of the EBMT | Zendy

Johanna Waidhauser | Zendy; Myriam Labopin | Zendy; Jordi Esteve | Zendy; Nicolaus Kröger | Zendy; Jan J. Cornelissen | Zendy; Tobias GeddeDahl | Zendy; Gwendolyn Van Gorkom | Zendy; Jürgen Finke | Zendy; Montserrat Rovira | Zendy; Nicolaas Schaap | Zendy; Eefke Petersen | Zendy; Dietrich W. Beelen | Zendy; Donald Bunjes | Zendy; Christoph Schmid | Zendy; Ar Nagler | Zendy; Mohamad Mohty | Zendy

Open Access

Allogeneic Stem Cell Transplantation for AML Patients with RUNX1 Mutation in First Complete Remission: A Study on Behalf of the ALWP of the EBMT

Author(s) -

Johanna Waidhauser,

Myriam Labopin,

Jordi Esteve,

Nicolaus Kröger,

Jan J. Cornelissen,

Tobias GeddeDahl,

Gwendolyn Van Gorkom,

Jürgen Finke,

Montserrat Rovira,

Nicolaas Schaap,

Eefke Petersen,

Dietrich W. Beelen,

Donald Bunjes,

Christoph Schmid,

Ar Nagler,

Mohamad Mohty

Publication year - 2020

Publication title -

biology of blood and marrow transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.301

H-Index - 120

eISSN - 1523-6536

pISSN - 1083-8791

DOI - 10.1016/j.bbmt.2019.12.072

Subject(s) - medicine , npm1 , cebpa , cumulative incidence , oncology , myeloid leukemia , transplantation , runx1 , leukemia , hematopoietic stem cell transplantation , stem cell , mutation , haematopoiesis , biology , karyotype , gene , genetics , chromosome

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research